(Q45141490)

10 December 2017

title

Intraoperative detection of disappearing colorectal liver metastases as a predictor of residual disease (English)

1 reference

10 December 2017

Alessandro Ferrero

1

1 reference

10 December 2017

Serena Langella

2

1 reference

10 December 2017

Nadia Russolillo

3

1 reference

10 December 2017

Luca Vigano'

4

1 reference

10 December 2017

Roberto Lo Tesoriere

5

1 reference

10 December 2017

Lorenzo Capussotti

6

1 reference

10 December 2017

publication date

19 January 2012

1 reference

Journal of Gastrointestinal Surgery

10 December 2017

published in

1 reference

10 December 2017

volume

16

1 reference

10 December 2017

issue

4

1 reference

10 December 2017

page(s)

806-814

1 reference

https://scigraph.springernature.com/pub.10.1007/s11605-011-1810-5

10 December 2017

exact match

0 references

cites work

Perioperative chemotherapy with FOLFOX4 and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC Intergroup trial 40983): a randomised controlled trial

1 reference

https://api.crossref.org/works/10.1007%2FS11605-011-1810-5

Bevacizumab improves pathologic response and protects against hepatic injury in patients treated with oxaliplatin-based chemotherapy for colorectal liver metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11605-011-1810-5

Tumour response and secondary resectability of colorectal liver metastases following neoadjuvant chemotherapy with cetuximab: the CELIM randomised phase 2 trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11605-011-1810-5

Systematic review of randomized and nonrandomized trials of the clinical response and outcomes of neoadjuvant systemic chemotherapy for resectable colorectal liver metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11605-011-1810-5

Association of computed tomography morphologic criteria with pathologic response and survival in patients treated with bevacizumab for colorectal liver metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11605-011-1810-5

Pathologic response to preoperative chemotherapy: a new outcome end point after resection of hepatic colorectal metastases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11605-011-1810-5

Impact of complete response to chemotherapy on overall survival in advanced colorectal cancer: results from Intergroup N9741.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11605-011-1810-5

Complete response of colorectal liver metastases after chemotherapy: does it mean cure?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11605-011-1810-5

Disappearing colorectal liver metastases after chemotherapy: should we be concerned?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11605-011-1810-5

Management of disappearing colorectal hepatic metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11605-011-1810-5

Optimizing resection for “responding” hepatic metastases after neoadjuvant chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11605-011-1810-5

Patient variability in intraoperative ultrasonographic characteristics of colorectal liver metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11605-011-1810-5

Design and validation of a histological scoring system for nonalcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11605-011-1810-5

The effects of cancer chemotherapy on liver imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11605-011-1810-5

Laparoscopic ultrasound vs triphasic computed tomography for detecting liver tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11605-011-1810-5

Intraoperative ultrasonography in liver cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11605-011-1810-5

Demonstration of hepatic steatosis by computerized tomography in patients receiving 5-fluorouracil-based therapy for advanced colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11605-011-1810-5

Effects of oral 5-fluorouracil drugs on hepatic fat content in patients with colon cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11605-011-1810-5

Chemotherapy regimen predicts steatohepatitis and an increase in 90-day mortality after surgery for hepatic colorectal metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11605-011-1810-5

Impact of chemotherapy on the accuracy of computed tomography scan for the evaluation of colorectal liver metastases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11605-011-1810-5

Chemotherapy-induced normalization of FDG uptake by colorectal liver metastases does not usually indicate complete pathologic response.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11605-011-1810-5

Effectiveness of positron emission tomography for predicting chemotherapy response in colorectal cancer liver metastases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11605-011-1810-5

The role and limitations of 18-fluoro-2-deoxy-D-glucose positron emission tomography (FDG-PET) scan and computerized tomography (CT) in restaging patients with hepatic colorectal metastases following neoadjuvant chemotherapy: comparison with operati

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11605-011-1810-5

Colorectal liver metastases: CT, MR imaging, and PET for diagnosis--meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11605-011-1810-5

Performance of imaging modalities in diagnosis of liver metastases from colorectal cancer: a systematic review and meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11605-011-1810-5

Preoperative detection of colorectal liver metastases in fatty liver: MDCT or MRI?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11605-011-1810-5

The value of intraoperative ultrasound during hepatic resection compared with improved preoperative magnetic resonance imaging.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11605-011-1810-5

The effect of steatosis on echogenicity of colorectal liver metastases on intraoperative ultrasonography

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11605-011-1810-5

Contrast-enhanced intraoperative ultrasonography during hepatectomies for colorectal cancer liver metastases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11605-011-1810-5

Extended preoperative chemotherapy does not improve pathologic response and increases postoperative liver insufficiency after hepatic resection for colorectal liver metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11605-011-1810-5

Predictors of a true complete response among disappearing liver metastases from colorectal cancer after chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11605-011-1810-5

Postchemotherapy characteristics of hepatic colorectal metastases: remnants of uncertain malignant potential

21 January 2018

1 reference

12 December 2020

Importance of complete pathologic response to prehepatectomy chemotherapy in treating colorectal cancer metastases

1 reference

12 December 2020

Potential value of contrast-enhanced intraoperative ultrasonography during partial hepatectomy for metastases: an essential investigation before resection?

1 reference

12 December 2020

Outcome of Posthepatectomy-Missing Colorectal Liver Metastases after Complete Response to Chemotherapy: Impact of Adjuvant Intra-arterial Hepatic Oxaliplatin

1 reference

12 December 2020

Importance of histological tumor response assessment in predicting the outcome in patients with colorectal liver metastases treated with neo-adjuvant chemotherapy followed by liver surgery

1 reference

12 December 2020

Patients with initially unresectable colorectal liver metastases: is there a possibility of cure?

1 reference

12 December 2020

Complete pathologic response after preoperative chemotherapy for colorectal liver metastases: myth or reality?

1 reference

12 December 2020

10.1007/S11605-011-1810-5

Identifiers

DOI

1 reference

Dimensions Publication ID

10 December 2017

1032185784

0 references

1 reference